BME 273 Senior Design Project Group 25 - PowerPoint PPT Presentation

1 / 19
About This Presentation
Title:

BME 273 Senior Design Project Group 25

Description:

Title: Business Strategy Author: dempserd Last modified by: John Richardson Created Date: 1/24/2006 11:52:58 PM Document presentation format: On-screen Show – PowerPoint PPT presentation

Number of Views:99
Avg rating:3.0/5.0
Slides: 20
Provided by: dem140
Category:

less

Transcript and Presenter's Notes

Title: BME 273 Senior Design Project Group 25


1
BME 273Senior Design ProjectGroup 25MEMs in
the Market
2
Problem
  • Drug companies demand a MEMs device that allows
    mobile, On-Chip drug testing, but at this point,
    that demand has not been met

3
Business Strategy
  • Objective Developing a strategy to market this
    BioMEMS device to major drug companies
  • Customer Major drug development and drug
    delivery companies

4
Market Potential
Microfluidics/LOC revenue forecasts 2004-2012
  • Worldwide MEMS market estimate
  •      (in billions of )                  
      2003    3.85           2004    4.5        
      2005    5.4           2006    6.2        
      2007    7
  • Source Yole Development

            2005 forecast MEMS markets by sector
                         Automotive  41    
        Telecom     29             Bio-med  
  16             Military     3          
  Other       11                      
 Source Peripheral Research Corp, Santa Barbara,
Calif.
5
Corporate Environment
Microfluidics/LOC competitive market share, 2004
6
Market Drivers
  • Cost efficiency
  • Currently, 400-800 million and 10 years per drug
  • Reduced sample size ? Lowers cost by decreasing
    reagent and labor usage
  • lt1 per BioMEMS chip
  • Scale up the number of cell cultures per
    experiment
  • Higher speed ? faster experiments
  • Greater control and modularity
  • Portable experimentation
  • Reduction of human error

7
Market Barriers
  • Government regulation of medical devices
  • Class I device regulated by FDA
  • Lack of a BioMEMS technological standard
  • Replacing old systems with new technologies
  • Reluctance from conservative pharm. companies
  • Scaling up production of prototypes
  • Many possible manufacturing problems

8
Device Construction
  • Objective Our primary objective is to create a
    MEMs On-Chip dual cell culture device at the
    pico-liter volume scale that allows for automated
    cell culturing and sensing for the testing of
    drugs and other perfused substances.

9
Goals
  • Primary goal
  • Create two cell cultures, each 720 pico-liter
    volumes, on one chip according to previous
    specifications
  • Show that these cell cultures allow for cells to
    retain life during experiments
  • Secondary goals
  • Create On-Chip sensors that allow us to sense the
    metabolism/response of cells to different stimuli
    (i.e., drugs)

10
Solution Original
  • Dual cell design with two waste channels to allow
    independent experiments
  • Dual pressure gauges to allow closure of entrance
    and exit channels for cell capturing
  • Checkerboard cell culture to capture cells in
    troughs

11
Solution
  • This is the mask for the primary experiment.
    Alterations to original drawing due to channel
    flow restrictions and MEMS practicality
  • Dimensions
  • Cell culture
  • 600 nm x 600 nm
  • Perfusion Channels
  • Maximum
  • 30 nm
  • Minimum
  • 10 nm

12
Solution Continued
  • These are the pressure values that will be placed
    on the layer above the channels to allow for air
    pressure to shut off specified channels on demand
  • Fabricated separately onto a different layer

13
Products thus far
  • Mask delivered
  • Primary device created
  • Next step Show cell viability

14
Devices Used
15
Solution
  • Secondary Design

16
Solution
  • Experimental Methods
  • Load cells into device
  • Begin perfusion
  • Wait 24 hrs., 48 hrs., etc.
  • At different times periods test cell viability
    via fluorescence
  • Test fluorescence via imaging

17
Materials
  • Polydimethlysiloxane (PDMS)
  • Negative Resist (SU-8)
  • Silicon Wafers
  • MEMS laboratory
  • 8 mm masks
  • Platinum (working electrodes)
  • Silver (reference Ag/AgCl electrodes)

18
Fabrication Steps
  • Lay down SU-8 on silicon wafer, expose using
    mask, and develop lower region for cell insertion
    and perfusion.
  • Cast PDMS replica of master
  • Lay down SU-8 on silicon wafer, expose using
    mask, and develop upper region for pneumatic
    control of cell insertion channels.
  • Cast PDMS replica of master and then lay over top
    of lower region

19
References
  • Fabrication of miniature Clark oxygen sensor
    integrated with microstructure
  • Ching-Chou Wu, Tomoyuki Yasukawa, Hitoshi Shiku,
    Tomokazu Matsue
  • A BioMEMS Review MEMS Technology for
    Physiologically Integrated Devices
  • AMY C. RICHARDS GRAYSON, REBECCA S. SHAWGO,
    AUDREY M. JOHNSON, NOLAN T. FLYNN, YAWEN LI,
    MICHAEL J. CIMA, AND ROBERT LANGER
  • Bouchaud, Jeremie. BioMEMS high potential but
    also highly challenging. Wicht Technology
    Consulting, Munich. 21 February 2006.
  • Clark, Lauren. BioMEMS Mini Medical Devices
    with Major Market Potential. MIT Deshpande
    Center Ignition Forum. 8 December 2003.
    http//web.mit.edu/deshpandecenter
  • Allan, Roger. BioMEMS Making Huge Inroads Into
    Medical Market. Electronic Design. 16 June
    2003. http//www.elecdesign.com/Articles/Index.cf
    m?AD1AD1ArticleID5050
  • Brown, Chappell. Chip Makers Looking at
    BioMEMS. EE Times Online. 27 March 2003.
    http//www.eet.com/story/OEG20030327S0019
Write a Comment
User Comments (0)
About PowerShow.com